Initial Data from Omeros' (OMER) OMS721 Phase 2 Data Shows Promise - Needham & Company
Tweet Send to a Friend
Needham & Company affirms Omeros (Nasdaq: OMER) with a Buy rating and $32 price target following initial OMS721 phase 2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
